A Required Parameters of Pyruvate Dehydrogenase Complex Deficiency (PDCD) Include Etiology, Clinical Description, Diagnostic Methods, Features of Primary PDCD, Differential Diagnosis, Management as well as Treatment and Prognosis
Abstract
Although its onset varies, Pyruvate Dehydrogenase Complex Deficiency (PDCD) is a rare genetic mitochondrial disorder that impairs the metabolism of carbohydrates and causes severe neurological dysfunction, lactic acidosis, and energy failure. It frequently results in early childhood death. resulting from mutations in the gene (usually PDHA1), It prevents pyruvate from being converted to acetyl-CoA, which stops the citric acid cycle and results in pyruvate/lactate accumulation that affects the heart, brain, and muscles. Although effective treatment is still scarce, management centers on ketogenic diets, supplements (thiamine, carnitine), and occasionally dichloroacetate.
References
Ah Mew, N., Loewenstein, J. B., Kadom, N., Lichter-Konecki, U., Gropman, A. L., Martin, J. M., & Vanderver, A. (2011). MRI features of four female patients with pyruvate dehydrogenase E1 alpha deficiency. Pediatric Neurology, 45(1), 57–59. https://doi.org/10.1016/j.pediatrneurol.2011.04.003
Barcelos, I., Shadiack, E., Ganetzky, R. D., & Falk, M. J. (2020). Mitochondrial medicine therapies: Rationale, evidence, and dosing guidelines. Current Opinion in Pediatrics, 32(6), 707–718. https://doi.org/10.1097/MOP.0000000000000948
Barnerias, C., Saudubray, J. M., Touati, G., De Lonlay, P., Dulac, O., Ponsot, G., Marsac, C., Brivet, M., & Desguerre, I. (2010). Pyruvate dehydrogenase complex deficiency: Four neurological phenotypes with differing pathogenesis. Developmental Medicine & Child Neurology, 52(2), e1–e9. https://doi.org/10.1111/j.1469-8749.2009.03541.x
Bedoyan, J. K., Hage, R., Shin, H. K., Linard, S., Ferren, E., Ducich, N., Wilson, K., Lehman, A., Schillaci, L. A., Manickam, K., Mori, M., Bartholomew, D., DeBrosse, S. D., Cohen, B., Parikh, S., & Kerr, D. S. (2020). Utility of specific amino acid ratios in screening for pyruvate dehydrogenase complex deficiencies and other mitochondrial disorders associated with congenital lactic acidosis and newborn screening prospects. JIMD Reports, 56, 70–81. https://doi.org/10.1002/jmd2.12129
Bedoyan, J. K., Hecht, L., Zhang, S., Tarrant, S., Bergin, A., Demirbas, D., Yang, E., Shin, H. K., Grahame, G. J., DeBrosse, S. D., Hoppel, C. L., Kerr, D. S., & Berry, G. T. (2019). A novel null mutation in the pyruvate dehydrogenase phosphatase catalytic subunit gene (PDP1) causing pyruvate dehydrogenase complex deficiency. JIMD Reports, 48, 26–35. https://doi.org/10.1002/jmd2.12033
Bedoyan, J. K., Yang, S. P., Ferdinandusse, S., Jack, R. M., Miron, A., Grahame, G., DeBrosse, S. D., Hoppel, C. L., Kerr, D. S., & Wanders, R. J. A. (2017). Lethal neonatal case and review of primary short-chain enoyl-CoA hydratase deficiency associated with secondary lymphocyte pyruvate dehydrogenase complex deficiency. Molecular Genetics and Metabolism, 120(4), 342–349. https://doi.org/10.1016/j.ymgme.2017.01.006
Cameron, J. M., Levandovskiy, V., Mackay, N., Tein, I., & Robinson, B. H. (2004). Deficiency of pyruvate dehydrogenase caused by novel and known mutations in the E1α subunit. American Journal of Medical Genetics Part A, 131A(1), 59–66. https://doi.org/10.1002/ajmg.a.30351
Castiglioni, C., Verrigni, D., Okuma, C., Diaz, A., Alvarez, K., Rizza, T., Carrozzo, R., Bertini, E., & Miranda, M. (2015). Pyruvate dehydrogenase deficiency presenting as isolated paroxysmal exercise-induced dystonia successfully reversed with thiamine supplementation: Case report and mini-review. European Journal of Paediatric Neurology, 19(4), 497–503. https://doi.org/10.1016/j.ejpn.2015.04.005
Chun, K., MacKay, N., Petrova-Benedict, R., & Robinson, B. H. (1993). Mutations in the X-linked E1 alpha subunit of pyruvate dehydrogenase leading to deficiency of the pyruvate dehydrogenase complex. Human Molecular Genetics, 2(4), 449–454. https://doi.org/10.1093/hmg/2.4.449
Clarke, C., Xiao, R., Place, E., Zhang, Z., Sondheimer, N., Bennett, M., Yudkoff, M., & Falk, M. J. (2013). Mitochondrial respiratory chain disease discrimination by retrospective cohort analysis of blood metabolites. Molecular Genetics and Metabolism, 110(1–2), 145–152. https://doi.org/10.1016/j.ymgme.2013.07.003
De Meirleir, L., Lissens, W., Denis, R., Wayenberg, J. L., Michotte, A., Brucher, J. M., Vamos, E., Gerlo, E., & Liebaers, I. (1993). Pyruvate dehydrogenase deficiency: Clinical and biochemical diagnosis. Pediatric Neurology, 9(3), 216–220. https://doi.org/10.1016/0887-8994(93)90009-Q
DeBrosse, S. D., Okajima, K., Zhang, S., Nakouzi, G., Schmotzer, C. L., Lusk-Kopp, M., Frohnapfel, M. B., Grahame, G., & Kerr, D. S. (2012). Spectrum of neurological and survival outcomes in pyruvate dehydrogenase complex deficiency: Lack of correlation with genotype. Molecular Genetics and Metabolism, 107(3), 394–402. https://doi.org/10.1016/j.ymgme.2012.08.005
Deeb, K. K., Bedoyan, J. K., Wang, R., Sremba, L., Schroeder, M. C., Grahame, G. J., Boyer, M., McCandless, S. E., Kerr, D. S., & Zhang, S. (2014). Somatic mosaicism for a novel PDHA1 mutation in a male with severe pyruvate dehydrogenase complex deficiency. Molecular Genetics and Metabolism Reports, 1, 362–367. https://doi.org/10.1016/j.ymgmr.2014.07.003
Ferriero, R., Boutron, A., Brivet, M., Kerr, D., Morava, E., Rodenburg, R. J., Bonafé, L., Baumgartner, M. R., Anikster, Y., Braverman, N. E., & Brunetti-Pierri, N. (2014). Phenylbutyrate increases pyruvate dehydrogenase complex activity in cells harboring a variety of defects. Annals of Clinical and Translational Neurology, 1(6), 462–470. https://doi.org/10.1002/acn3.77
Fouque, F., Brivet, M., Boutron, A., Vequaud, C., Marsac, C., Zabot, M. T., & Benelli, C. (2003). Differential effect of dichloroacetate treatment on the pyruvate dehydrogenase complex in patients with severe pyruvate dehydrogenase complex deficiency. Pediatric Research, 53(5), 793–799. https://doi.org/10.1203/01.PDR.0000057478.31158.8B
Refbacks
- There are currently no refbacks.